Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Cash from Investing Activities (2020 - 2023)

Journey Medical's Cash from Investing Activities history spans 4 years, with the latest figure at -$5.0 million for Q1 2023.

  • For the quarter ending Q1 2023, Cash from Investing Activities rose 75.0% year-over-year to -$5.0 million, compared with a TTM value of -$5.0 million through Dec 2023, up 75.0%, and an annual FY2024 reading of -$15.0 million, down 200.0% over the prior year.
  • Cash from Investing Activities for Q1 2023 was -$5.0 million at Journey Medical, up from -$20.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$200000.0 in Q4 2020, with the low at -$20.0 million in Q1 2022.
  • Average Cash from Investing Activities over 4 years is -$6.6 million, with a median of -$3.1 million recorded in 2021.
  • Year-over-year, Cash from Investing Activities crashed 500.0% in 2021 and then soared 75.0% in 2023.
  • Tracing DERM's Cash from Investing Activities over 4 years: stood at -$200000.0 in 2020, then crashed by 500.0% to -$1.2 million in 2021, then crashed by 1566.67% to -$20.0 million in 2022, then soared by 75.0% to -$5.0 million in 2023.
  • Per Business Quant, the three most recent readings for DERM's Cash from Investing Activities are -$5.0 million (Q1 2023), -$20.0 million (Q1 2022), and -$1.2 million (Q4 2021).